-+ 0.00%
-+ 0.00%
-+ 0.00%

Pharming Launches Joenja (Leniolisib) in Japan for APDS Patients Aged 4 and Older, Marking First Global Launch for Children 4 To 11

Benzinga·08/13/2026 05:07:54
Listen to the news
  • Launch marks first commercial availability of Joenja® (leniolisib) for children aged 4 to 11 worldwide
  • OrphanPacific, Inc. serves as Marketing Authorization holder and is responsible for supply and distribution in Japan